Vertex Pharmaceuticals

Are Biotech Stocks Due for a Correction in 2020?
Are Biotech Stocks Due for a Correction in 2020?
Motley Fool
biotech stocks
Axsome Therapeutics
Seattle Genetics
Vertex Pharmaceuticals
Flag link:
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
#JPM20: Vertex lays out post-CF ambitions as Gilead demurs on acquisition
Endpoints
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2020
Gilead Sciences
M&A
Flag link:
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations
Yahoo/Benzinga
JPMHC 2020
Bristol-Myers Squibb
Vertex Pharmaceuticals
Biomarin
Regeneron
Biogen
Alexion
Gilead Sciences
Amgen
Flag link:
The 4 biggest pharma market access stories of 2019
The 4 biggest pharma market access stories of 2019
Pharmaforum
biosimilars
UK
Orkambi
Vertex Pharmaceuticals
drug pricing
FDA
NICE
Flag link:
5 New Drug Approvals the FDA Gave Top Priority
5 New Drug Approvals the FDA Gave Top Priority
Motley Fool
FDA
drug approvals
Global Blood Therapeutics
Oxbryta
Alnylam
Givlaari
BeiGene
Brukinsa
Vertex Pharmaceuticals
Flag link:
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates
RAPS.org
FDA
Vertex Pharmaceuticals
Trikafta
Novartis
Adakveo
Alnylam
Givlaari
BeiGene
Brukinsa
Global Blood Therapeutics
Oxbryta
drug approvals
Flag link:
Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials
Vertex’s triple therapy will reshape the landscape of cystic fibrosis trials
BioCentury
Vertex Pharmaceuticals
FDA
cystic fibrosis
Trikafta
Flag link:
A deal-hungry Vertex ushers in three more gene editing programs as it closes out harbinger CRISPR deal
A deal-hungry Vertex ushers in three more gene editing programs as it closes out harbinger CRISPR deal
Endpoints
Vertex Pharmaceuticals
CRISPR
gene editing
CTX001
Flag link:
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines
Stat
Vertex Pharmaceuticals
cystic fibrosis
UK
Flag link:
‘A game-changer’: How Vertex delivered on cystic fibrosis
‘A game-changer’: How Vertex delivered on cystic fibrosis
Stat
Vertex Pharmaceuticals
cystic fibrosis
Trikafta
Flag link:
New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients
Stat
Vertex Pharmaceuticals
cystic fibrosis
FDA
Trikafta
Flag link:
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
Biopharma M&A: deal-depressed third quarter leaves nowhere to hide
EP Vantage
M&A
Lundbeck
Alder Biopharmaceuticals
Gilead Sciences
Galapagos
Vertex Pharmaceuticals
Semma
Swedish Orphan Biovitrum
Dova Pharmaceuticals
Novartis
IFM
Flag link:
3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year
3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year
Motley Fool
Vertex Pharmaceuticals
cystic fibrosis
gene editing
Flag link:
Vertex hits a biomarker bump on road to new drug
Vertex hits a biomarker bump on road to new drug
Biopharma Dive
Vertex Pharmaceuticals
AAT
VX-814
Flag link:
Vertex deal for Scotland — no deal for England
Vertex deal for Scotland — no deal for England
Endpoints
Vertex Pharmaceuticals
cystic fibrosis
Scotland
England
UK
Symkevi
Orkambi
Flag link:
Don’t Blink or You’ll Miss Vertex’s Next Move, And It’s Bound to Be a Good One
Don’t Blink or You’ll Miss Vertex’s Next Move, And It’s Bound to Be a Good One
Motley Fool
Vertex Pharmaceuticals
Flag link:
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Vertex’s next act: a billion-dollar bet on a cure for type 1 diabetes
Stat
Vertex Pharmaceuticals
M&A
diabetes
type 1 diabetes
Semma Therapeutics
Flag link:
Vertex sinks on reports of patient deaths tied to cystic fibrosis drug
Vertex sinks on reports of patient deaths tied to cystic fibrosis drug
Stat
Vertex Pharmaceuticals
cystic fibrosis
patient deaths
Symdeko
Flag link:
FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup
FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup
Endpoints
Vertex Pharmaceuticals
FDA
cystic fibrosis
VX-445
tezacaftor/ivacaftor
Flag link:
What happened a year ago this week in biopharma? August 12-18, 2018
Regeneron
Novartis
wet-AMD
Eylea
ethics
Vertex Pharmaceuticals
Kalydeco
cystic fibrosis
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
SCLC
Flag link:

Pages